Public Company News

Honeywell Teams with AstraZeneca to Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant

* Next-generation inhaler will use Honeywell's Solstice® Air to reduce greenhouse gas emissions of propellant by up to 99.9 percent vs current inhaler propellant * Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through in...

2022-04-11 09:00 2282

SCMP Magazine Integrates IAS's Publisher Optimisation Solutions to Deliver Quality Impressions for its Advertisers

HONG KONG, April 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, today announced the integration of its Publisher Optimisation Solution with SCMP Magazines,Hong Kong's leading magazine publisher with a portfolio of premium lifestyle and fashio...

2022-04-11 08:30 2157

Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

The company will present the preclinical data of five novel drug candidates at AACR 2022 (onApril 8-13). Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, April 11, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovativ...

2022-04-11 08:30 4178

Innovent Release Phase 1 Results of IBI322 (anti-PD-L1/CD47 bispecific antibody) in patients with advanced solid tumors at AACR Annual Meeting 2022

SAN FRANCISCO and SUZHOU, China, April 11, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2022-04-11 08:14 3464

TRICORBRAUN TO ACQUIRE PB PACKAGING, EXPANDING ITS PRESENCE IN AUSTRALIA

ST. LOUIS, April 11, 2022 /PRNewswire/ -- Global packaging leader TricorBraun announced today that it has entered into an agreement to acquire PB Packaging ("PB"), a wholly-owned business of Pro-Pac Packaging Limited (ASX: PPG) ("Pro-Pac"), expanding its presence inAustralia. One of Australia's ...

2022-04-11 07:01 1630

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

MELBOURNE, Australia and INDIANAPOLIS, April 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Company ("Lilly") under which Telix is granted exclusive worldwide rights to devel...

2022-04-11 06:51 2863

Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis

-- Gannex is expected to complete the Phase II trial in 100 patients by the end of 2022. -- Gannex intends to soon start a Phase III trial in China, the U.S. and European Union after the completion of the Phase II study inChina. -- An epidemiology study in China in 2010 showed that there were a...

2022-04-10 18:20 2501

Zhihu Inc. Launches Global Offering

BEIJING, April 8, 2022 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH) ("Zhihu" or the "Company"), the operator of Zhihu, a leading online content community inChina, today announced the launch of its global offering (the "Global Offering") of 26,000,000 Class A ordinary shares of the Company, which compris...

2022-04-09 04:56 6747

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL

Allogeneic, off-the-shelf CAR-T therapy with CD19/CD7 dual-directed CAR shows promising early results in patients with r/r B-ALL PALO ALTO, Calif. and SUZHOU, China, April 8, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage bio...

2022-04-09 04:00 4214

Samyang Foods sponsors BTS PERMISSION TO DANCE ON STAGE - LAS VEGAS

- Part of global promotion campaign of K-spicy to commemorate the 10th anniversary of the launching Buldak SEOUL, South Korea, April 8, 2022 /PRNewswire/ -- Samyang Foods announced on April 8 that it will participate as the main sponsor of BTS PERMISSION TO DANCE ON STAGE –LAS VEGAS, commemorati...

2022-04-09 00:00 4573

Bactiguard enters development partnership in the dental field

STOCKHOLM, April 8, 2022 /PRNewswire/ -- Bactiguard today entered an agreement to initiate a global development partnership with Dentsply Sirona in the dental field, a new application area for the Bactiguard technology. The initial development phase, which is expected to last approximately one y...

2022-04-08 22:54 4362

LG INTRODUCES 'FUTURE HOME GLOBAL INNOVATION CHALLENGE' AT ALPHA WOLVES SUMMIT

In Partnership with Wolves Summit, Company Launches Competition to Discover Innovative Technologies and Solutions for a Better Life at Home SEOUL, South Korea, April 8, 2022 /PRNewswire/ -- LG Electronics (LG) announcedLG Future Home Global Innovation Challenge

2022-04-08 22:00 3979

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand

GAITHERSBURG, Md., and PUNE, India, April 8, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine ...

2022-04-08 21:00 5835

KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS

SYDNEY, April 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce new preclinical data demonstrating the activity of paxalisib in two forms of childhood brain cancer with very high unmet medical need. ...

2022-04-08 20:30 4143

Zhihu Inc. Files Its Annual Report on Form 20-F

BEIJING, April 8, 2022 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH), the operator of Zhihu, a leading online content community inChina, today announced that it filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2021 with the Securities and Exchange Comm...

2022-04-08 20:16 6113

OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and AST liver marker levels observed in monkey models * Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ -- OliX ...

2022-04-08 20:00 3688

TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESIGN AND INNOVATIVE BIOMARKER STRATEGY FOR ONGOING PHASE I STUDY OF EVT801 IN ADVANCED CANCER

SYDNEY, April 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two presentations detailing the ongoing phase I study of the company's investigational novel drug, EVT801, a selective VEGFR3 ...

2022-04-08 20:00 3911

Renren Inc. Announces Software License Agreement

PHOENIX, April 8, 2022 /PRNewswire/ -- Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), announces today that the Company, has signed a Software License and Distribution Agreement ("License Agreement") with Guangzhou Yupu Software Technology Co., Ltd. ("Guangzhou Yupu"). The License Agreement...

2022-04-08 19:00 3321

CNOOC Limited Announces Weizhou 12-8E Oilfield Development Project Commenced Production

HONG KONG, April 8, 2022 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883) announced today that Weizhou 12-8E oilfield development project has commenced production. The Weizhou 12-8E oilfield development project is located in Beibu Gulf in the South China Sea, with average water depth...

2022-04-08 18:19 5704

ChipMOS REPORTS 12.3% MoM INCREASE IN MARCH 2022 MONTHLY REVENUE; 4.0% YoY INCREASE IN 1Q22 QUARTERLY REVENUE

HSINCHU, April 8, 2022 /PRNewswire-FirstCall / -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT")...

2022-04-08 18:00 5577